Balchem (BCPC) Earns Daily News Impact Rating of 0.03

News articles about Balchem (NASDAQ:BCPC) have trended somewhat positive this week, Accern reports. The research group rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Balchem earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave media coverage about the basic materials company an impact score of 45.9340279217046 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Balchem (NASDAQ:BCPC) opened at $82.02 on Friday. Balchem has a 1 year low of $71.95 and a 1 year high of $89.50. The company has a market capitalization of $2,624.97, a P/E ratio of 32.42 and a beta of 1.10. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.49 and a current ratio of 2.16.

Balchem (NASDAQ:BCPC) last announced its quarterly earnings data on Tuesday, November 7th. The basic materials company reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.01. The firm had revenue of $150.72 million for the quarter. Balchem had a return on equity of 14.68% and a net margin of 11.11%.

The company also recently disclosed an annual dividend, which was paid on Friday, January 19th. Investors of record on Wednesday, December 27th were issued a $0.42 dividend. This represents a dividend yield of 0.5%. The ex-dividend date was Tuesday, December 26th. This is an increase from Balchem’s previous annual dividend of $0.38. Balchem’s payout ratio is currently 21.11%.

Separately, BidaskClub lowered Balchem from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th.

COPYRIGHT VIOLATION WARNING: “Balchem (BCPC) Earns Daily News Impact Rating of 0.03” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at

About Balchem

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Insider Buying and Selling by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with's FREE daily email newsletter.

Leave a Reply